• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.60% Nasdaq Down 0.39%

    NovaBay Pharmaceuticals, Inc. (NBY)

    -NYSE MKT
    1.90 Down 0.02(1.04%) 3:58PM EST
    Prev Close:1.92
    Open:1.97
    Bid:1.90 x 5900
    Ask:1.92 x 400
    1y Target Est:30.00
    Beta:-0.617329
    Earnings Date:Mar 24 - Mar 28 (Est.)
    Day's Range:1.90 - 1.97
    52wk Range:1.75 - 26.25
    Volume:7,859
    Avg Vol (3m):36,244
    Market Cap:6.62M
    P/E (ttm):N/A
    EPS (ttm):-7.93
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBY

    Comparison

    Symbol% ChgMkt Cap
    NBYDown 1.04%6.62M
    ABTDown 2.34%54.21B
    SNNDown 2.95%13.66B
    PFEDown 1.22%179.83B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.07
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-17.67
    Quarterly EPS Est (Dec-15) :-17.75
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes topical non-antibiotic antimicrobial products for the eye care market. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback